Show simple item record

dc.contributor.authorZhang, Jing
dc.contributor.authorSong, Jie
dc.date2022-08-11T08:10:08.000
dc.date.accessioned2022-08-23T16:56:37Z
dc.date.available2022-08-23T16:56:37Z
dc.date.issued2014-07-01
dc.date.submitted2014-08-13
dc.identifier.citationActa Biomater. 2014 Jul;10(7):3079-90. doi: 10.1016/j.actbio.2014.02.051. Epub 2014 Mar 12. <a href="http://dx.doi.org/10.1016/j.actbio.2014.02.051">Link to article on publisher's site</a>
dc.identifier.issn1742-7061 (Linking)
dc.identifier.doi10.1016/j.actbio.2014.02.051
dc.identifier.pmid24631657
dc.identifier.urihttp://hdl.handle.net/20.500.14038/42967
dc.description.abstractControlled delivery of the angiogenic factor sphingosine 1-phosphate (S1P) represents a promising strategy for promoting vascularization during tissue repair and regeneration. In this study, we developed an amphiphilic biodegradable polymer platform for the stable encapsulation and sustained release of S1P. Mimicking the interaction between amphiphilic S1P and its binding proteins, a series of polymers with hydrophilic poly(ethylene glycol) core and lipophilic flanking segments of polylactide and/or poly(alkylated lactide) with different alkyl chain lengths were synthesized. These polymers were electrospun into fibrous meshes, and loaded with S1P in generally high loading efficiencies (>90%). Sustained S1P release from these scaffolds could be tuned by adjusting the alkyl chain length, blockiness and lipophilic block length, achieving 35-55% and 45-80% accumulative releases in the first 8h and by 7 days, respectively. Furthermore, using endothelial cell tube formation assay and chicken chorioallantoic membrane assay, we showed that the different S1P loading doses and release kinetics translated into distinct pro-angiogenic outcomes. These results suggest that these amphiphilic polymers are effective delivery vehicles for S1P and may be explored as tissue engineering scaffolds where the delivery of lipophilic or amphiphilic bioactive factors is desired. reserved.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=24631657&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1016/j.actbio.2014.02.051
dc.subjectAngiogenesis
dc.subjectDrug delivery
dc.subjectAmphiphilic copolymer
dc.subjectSphingosine-1-phosphate
dc.subjectTissue engineering
dc.subjectBiochemistry, Biophysics, and Structural Biology
dc.titleAmphiphilic degradable polymers for immobilization and sustained delivery of sphingosine 1-phosphate
dc.typeJournal Article
dc.source.journaltitleActa biomaterialia
dc.source.volume10
dc.source.issue7
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/ortho_pp/170
dc.identifier.contextkey5959065
html.description.abstract<p>Controlled delivery of the angiogenic factor sphingosine 1-phosphate (S1P) represents a promising strategy for promoting vascularization during tissue repair and regeneration. In this study, we developed an amphiphilic biodegradable polymer platform for the stable encapsulation and sustained release of S1P. Mimicking the interaction between amphiphilic S1P and its binding proteins, a series of polymers with hydrophilic poly(ethylene glycol) core and lipophilic flanking segments of polylactide and/or poly(alkylated lactide) with different alkyl chain lengths were synthesized. These polymers were electrospun into fibrous meshes, and loaded with S1P in generally high loading efficiencies (>90%). Sustained S1P release from these scaffolds could be tuned by adjusting the alkyl chain length, blockiness and lipophilic block length, achieving 35-55% and 45-80% accumulative releases in the first 8h and by 7 days, respectively. Furthermore, using endothelial cell tube formation assay and chicken chorioallantoic membrane assay, we showed that the different S1P loading doses and release kinetics translated into distinct pro-angiogenic outcomes. These results suggest that these amphiphilic polymers are effective delivery vehicles for S1P and may be explored as tissue engineering scaffolds where the delivery of lipophilic or amphiphilic bioactive factors is desired. reserved.</p>
dc.identifier.submissionpathortho_pp/170
dc.contributor.departmentDepartment of Orthopedics and Physical Rehabilitation
dc.source.pages3079-90


Files in this item

Thumbnail
Name:
Publisher version

This item appears in the following Collection(s)

Show simple item record